Christopher C Oakes
Overview
Explore the profile of Christopher C Oakes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi K, Abdelbaky S, Yu L, Oakes C, Abruzzo L, Coombes K
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858069
: Recent growth in the number and applications of high-throughput "omics" technologies has created a need for better methods to integrate multiomics data. Much progress has been made in developing...
2.
Arons E, Tai C, Suraj J, Liu Y, Day C, Raffeld M, et al.
Blood
. 2024 Dec;
PMID: 39719040
We found 18 patients with immunophenotype consistent with classic hairy cell leukemia (HCL) and BRAF mutations other than just V600E. Twelve had 1 non-V600E BRAF mutation and 6 had V600E...
3.
Charalampopoulou S, Chapiro E, Nadeu F, Zenz T, Bea S, Martinez-Farran A, et al.
Blood Adv
. 2024 Oct;
8(24):6297-6307.
PMID: 39471431
The recognition of B-cell prolymphocytic leukemia (B-PLL) as a separate entity is controversial based on the current classification systems. Here, we analyzed the DNA methylome of a cohort of 20...
4.
Stiff A, Fornerod M, Kain B, Nicolet D, Kelly B, Miller K, et al.
Nat Genet
. 2024 Oct;
56(11):2434-2446.
PMID: 39367245
Genomic profiles and prognostic biomarkers in patients with acute myeloid leukemia (AML) from ancestry-diverse populations are underexplored. We analyzed the exomes and transcriptomes of 100 patients with AML with genomically...
5.
Carr L, Norris K, Parker H, Nilsson-Takeuchi A, Bryant D, Amarasinghe H, et al.
Br J Haematol
. 2024 Sep;
205(5):2072-2076.
PMID: 39253978
No abstract available.
6.
Grever M, Andritsos L, Anghelina M, Arons E, Banerji V, Barrientos J, et al.
Leukemia
. 2024 Jun;
38(7):1642-1644.
PMID: 38851853
No abstract available.
7.
Cao X, Huber S, Ahari A, Traube F, Seifert M, Oakes C, et al.
Genome Med
. 2024 May;
16(1):70.
PMID: 38769532
Background: Rare oncogenic driver events, particularly affecting the expression or splicing of driver genes, are suspected to substantially contribute to the large heterogeneity of hematologic malignancies. However, their identification remains...
8.
Kleinstern G, Boddicker N, OBrien D, Allmer C, Rabe K, Norman A, et al.
Blood Adv
. 2024 Feb;
8(9):2118-2129.
PMID: 38359367
High-count monoclonal B-cell lymphocytosis (HCMBL) is a precursor condition to chronic lymphocytic leukemia (CLL). We have shown that among individuals with HCMBL, the CLL-International Prognostic Index (CLL-IPI) is prognostic for...
9.
Abdelbaky S, Giacopelli B, Rabe K, Yamaguchi K, Wu Y, Yan H, et al.
Blood
. 2024 Jan;
143(17):1752-1757.
PMID: 38194687
Monoclonal B-cell lymphocytosis (MBL) progresses to chronic lymphocytic leukemia (CLL) requiring therapy at 1% to 5% per year. Improved prediction of progression would greatly benefit individuals with MBL. Patients with...
10.
Ozga M, Nicolet D, Mrozek K, Yilmaz A, Kohlschmidt J, Larkin K, et al.
Leukemia
. 2023 Nov;
38(1):45-57.
PMID: 38017103
Clinical outcome of patients with acute myeloid leukemia (AML) is associated with demographic and genetic features. Although the associations of acquired genetic alterations with patients' sex have been recently analyzed,...